-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
June 01, 2014 - one expert expressed the caveat that the demand for donor lungs is much lower than the demand for
kidneys
-
effectivehealthcare.ahrq.gov/health-topics/gallstones
-
effectivehealthcare.ahrq.gov/health-topics/memory
-
effectivehealthcare.ahrq.gov/health-topics/diverticulosis-and-diverticulitis
-
effectivehealthcare.ahrq.gov/health-topics/colonoscopy
-
effectivehealthcare.ahrq.gov/health-topics/diabetic-foot
-
effectivehealthcare.ahrq.gov/health-topics/high-blood-pressure
-
effectivehealthcare.ahrq.gov/health-topics/a1c
-
effectivehealthcare.ahrq.gov/health-topics/blood-sugar
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
March 08, 2004 - Kidney International 1996;49(3):889-95.
83. Wolff C, Kleesiek K, Petersen N, Beyer J. … The long-term course of hepatitis C after kidney transplantation.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
March 01, 2004 - Kidney International.
1996;49(3):889–895.
83. Wolff C, Kleesiek K, Petersen N, Beyer J. … The long-term course of hepatitis C after kidney
transplantation.
-
digital.ahrq.gov/sites/default/files/docs/citation/ahrq-cdspain-technical-implementation-guide.pdf
March 01, 2024 - information for tapering of non-opioid medications, along with pertinent
laboratory results (liver and kidney
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-2013
April 15, 2013 - Better evidence is needed about the long-term harms of ART, including risks for cardiovascular and kidney
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - Long-term outcome after acute kidney
injury in critically-ill patients.
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017167-kopal-final-report-2011.pdf
January 01, 2011 - before and after the intervention as defined
by JNC-7 criteria (BP<130/80 for patients with diabetes or kidney
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
April 24, 2019 - is also associated w ith the major chronic diseases such diabetes, cardiovascular
disease, chronic kidney
-
effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
March 29, 2012 - Associations of kidney function with
cardiovascular medication use after
myocardial infarction.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - improved glycemic control
reduces microvascular complications (e.g.,
complications involving the eyes, kidneys
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
September 01, 2014 - now includes a warning
regarding the risk of nephrogenic systemic fibrosis in
patients with severe kidney
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - conditions:
• End-stage liver disease or cirrhosis
• End-stage renal disease (i.e., stage 5 chronic kidney